🇺🇸 FDA

Company profile · Sponsor

Protagenic

Protagenic Therapeutics, Inc.new

PTIX · NYSE pharma NEW YORK, NY, USA
Pipeline
1
Drugs
0
Patents
0

Quick answer

Protagenic (PTIX) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker PTIX
Exchange NYSE
Company type pharma
Headquarters NEW YORK, NY, USA
SEC CIK 0001022899

Pipeline (1)

Search pipeline →

  1. A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability and Pharmacological Effects of PT00114 in Healthy Volunteers

    Protagenic

    Phase I study in healthy male and female volunteers. Intended indication: mood disorders

    phase 1 other active

    1 trial

Frequently asked questions

What is Protagenic?

Protagenic (PTIX) is a pharma company. headquartered in NEW YORK, NY, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Protagenic sponsor?

We track 1 ClinicalTrials.gov-linked program for Protagenic, including A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability and Pharmacological Effects of PT00114 in Healthy Volunteers. Open each program for phase, modality, NCT IDs, and indication details.

Where does Protagenic company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.